Alpine Immune Sciences Inc. (ALPN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Alpine Immune Sciences In...

NASDAQ: ALPN · Real-Time Price · USD
64.97
0.01 (0.02%)
At close: May 17, 2024, 10:00 PM

Alpine Immune Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-32.18M -57.76M -50.33M
Depreciation & Amortization
576K 597K 620K
Stock-Based Compensation
10.63M 9.65M 6.24M
Other Working Capital
-56.91M -25.97M 21.07M
Other Non-Cash Items
-8.03M -475K 274K
Deferred Income Tax
155K 46K 910K
Change in Working Capital
-50.16M 4.19M 27.04M
Operating Cash Flow
-79.01M -43.75M -15.25M
Capital Expenditures
-487K -412K -118K
Cash Acquisitions
n/a 112.94M 52.36M
Purchase of Investments
-351.35M -266.98M -133.52M
Sales Maturities Of Investments
296.27M 154.05M 81.16M
Other Investing Acitivies
n/a -112.94M -52.36M
Investing Cash Flow
-55.56M -113.35M -52.48M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
165.12M 102.69M 100.76M
Financial Cash Flow
165.12M 102.69M 100.76M
Net Cash Flow
30.56M -54.53M 32.95M
Free Cash Flow
-79.5M -44.17M -15.37M